Atlas Trials

Initial Treatment With Bevacizumab in Choroidal Neovascularization Associated to High Myopia

Clinical trial NCT01716026 · COMPLETED

Trial details

NCT number
NCT01716026
Sponsor
Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Choroidal Subfoveal/Juxtafoveal Neovascularization in High Myopia
Start date
2012-10-01
Primary completion
2018-04-01
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.